<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>CPH:NOVOB on 无关紧要的宇宙</title><link>https://316140221.github.io/Hugo/zh/tags/cphnovob/</link><description>Recent content in CPH:NOVOB on 无关紧要的宇宙</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Thu, 18 Sep 2025 21:50:01 +0800</lastBuildDate><atom:link href="https://316140221.github.io/Hugo/zh/tags/cphnovob/index.xml" rel="self" type="application/rss+xml"/><item><title>Nvidia Invests $5 Billion in Intel | Open Interest 9/18/2025</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-09-18-nvidia-invests-5-billion-in-intel-open-interest-91/</link><pubDate>Thu, 18 Sep 2025 21:50:01 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-09-18-nvidia-invests-5-billion-in-intel-open-interest-91/</guid><description>Get a jump start on the US trading day with Matt Miller and Dani Burger on &amp;ldquo;Bloomberg Open Interest.&amp;rdquo; Nvidia is making headlines with a surprise $5 billion investment in rival Intel, sending Intel sha</description></item><item><title>Nvidia Invests $5 Billion in Intel | Open Interest 9/18/2025</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-18-nvidia-invests-5-billion-in-intel-open-interest-91/</link><pubDate>Thu, 18 Sep 2025 21:50:01 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-18-nvidia-invests-5-billion-in-intel-open-interest-91/</guid><description>Get a jump start on the US trading day with Matt Miller and Dani Burger on &amp;ldquo;Bloomberg Open Interest.&amp;rdquo; Nvidia is making headlines with a surprise $5 billion investment in rival Intel, sending Intel sha</description></item><item><title>Novo to Cut Workforce by 11%, CEO Lowers Profit Forecast</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-09-10-novo-to-cut-workforce-by-11-ceo-lowers-profit-fore/</link><pubDate>Wed, 10 Sep 2025 10:02:57 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-09-10-novo-to-cut-workforce-by-11-ceo-lowers-profit-fore/</guid><description>Novo Nordisk A/S will cut 9,000 jobs globally and reduce its profit forecast for the third time this year as the maker of Ozempic and Wegovy aims to save 8 billion kroner ($1.3 billion) by the end of</description></item><item><title>Novo to Cut Workforce by 11%, CEO Lowers Profit Forecast</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-10-novo-to-cut-workforce-by-11-ceo-lowers-profit-fore/</link><pubDate>Wed, 10 Sep 2025 10:02:57 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-10-novo-to-cut-workforce-by-11-ceo-lowers-profit-fore/</guid><description>Novo Nordisk A/S will cut 9,000 jobs globally and reduce its profit forecast for the third time this year as the maker of Ozempic and Wegovy aims to save 8 billion kroner ($1.3 billion) by the end of</description></item><item><title>WHO Adds Ozempic and Mounjaro to Its List of Essential Medicines</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-who-adds-ozempic-and-mounjaro-to-its-list-of-essen/</link><pubDate>Fri, 05 Sep 2025 13:00:00 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-who-adds-ozempic-and-mounjaro-to-its-list-of-essen/</guid><description>The World Health Organization added Novo Nordisk A/S’s Ozempic and Eli Lilly &amp;amp; Co.’s Mounjaro to its list of essential medicines, a step that may expand access to the drugs around the world.</description></item><item><title>WHO Adds Ozempic and Mounjaro to Its List of Essential Medicines</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-who-adds-ozempic-and-mounjaro-to-its-list-of-essen/</link><pubDate>Fri, 05 Sep 2025 13:00:00 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-who-adds-ozempic-and-mounjaro-to-its-list-of-essen/</guid><description>The World Health Organization added Novo Nordisk A/S’s Ozempic and Eli Lilly &amp;amp; Co.’s Mounjaro to its list of essential medicines, a step that may expand access to the drugs around the world.</description></item><item><title>Novo Slowdown to Hurt Danish GDP, Central Bank Governor Says</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-novo-slowdown-to-hurt-danish-gdp-central-bank-gove/</link><pubDate>Fri, 05 Sep 2025 04:02:27 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-novo-slowdown-to-hurt-danish-gdp-central-bank-gove/</guid><description>National Bank of Denmark Governor Christian Kettel Thomsen discusses the outlook for economic growth amid weakened sales growth at drug maker Novo Nordisk. The central bank will reduce its growth fore</description></item><item><title>Novo Slowdown to Hurt Danish GDP, Central Bank Governor Says</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-novo-slowdown-to-hurt-danish-gdp-central-bank-gove/</link><pubDate>Fri, 05 Sep 2025 04:02:27 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-novo-slowdown-to-hurt-danish-gdp-central-bank-gove/</guid><description>National Bank of Denmark Governor Christian Kettel Thomsen discusses the outlook for economic growth amid weakened sales growth at drug maker Novo Nordisk. The central bank will reduce its growth fore</description></item><item><title>Novo Nordisk Woes and Trump’s Tariffs Dent Danish Growth Outlook</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-g/</link><pubDate>Fri, 05 Sep 2025 04:00:00 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-g/</guid><description>Denmark’s central bank will cut its economic outlook for 2025 substantially because of weaker sales growth at Novo Nordisk A/S and US tariffs, according to its governor.</description></item><item><title>Novo Nordisk Woes and Trump’s Tariffs Dent Danish Growth Outlook</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-g/</link><pubDate>Fri, 05 Sep 2025 04:00:00 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-g/</guid><description>Denmark’s central bank will cut its economic outlook for 2025 substantially because of weaker sales growth at Novo Nordisk A/S and US tariffs, according to its governor.</description></item><item><title>Novo Nordisk Woes and Trump’s Tariffs Dent Danish Outlook</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-o/</link><pubDate>Fri, 05 Sep 2025 04:00:00 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-o/</guid><description>Denmark’s central bank will cut its economic outlook for 2025 substantially because of weaker sales growth at Novo Nordisk A/S and US tariffs, according to its governor.</description></item><item><title>Novo Nordisk Woes and Trump’s Tariffs Dent Danish Outlook</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-o/</link><pubDate>Fri, 05 Sep 2025 04:00:00 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-09-05-novo-nordisk-woes-and-trumps-tariffs-dent-danish-o/</guid><description>Denmark’s central bank will cut its economic outlook for 2025 substantially because of weaker sales growth at Novo Nordisk A/S and US tariffs, according to its governor.</description></item><item><title>Novo CFO: US Wegovy, Ozempic Prices to Keep Falling</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-08-06-novo-cfo-us-wegovy-ozempic-prices-to-keep-falling/</link><pubDate>Wed, 06 Aug 2025 09:09:44 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-08-06-novo-cfo-us-wegovy-ozempic-prices-to-keep-falling/</guid><description>The maker of Ozempic and Wegovy obesity drugs said some of the prices could come down, as President Trump called for drugmakers to immediately lower their prices for Medicaid. This comes as Novo Nordi</description></item><item><title>Novo CFO: US Wegovy, Ozempic Prices to Keep Falling</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-06-novo-cfo-us-wegovy-ozempic-prices-to-keep-falling/</link><pubDate>Wed, 06 Aug 2025 09:09:44 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-06-novo-cfo-us-wegovy-ozempic-prices-to-keep-falling/</guid><description>The maker of Ozempic and Wegovy obesity drugs said some of the prices could come down, as President Trump called for drugmakers to immediately lower their prices for Medicaid. This comes as Novo Nordi</description></item><item><title>European Stocks Subdued After Glum Novo Nordisk, Bayer Earnings</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-08-06-european-stocks-subdued-after-glum-novo-nordisk-ba/</link><pubDate>Wed, 06 Aug 2025 07:17:42 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-08-06-european-stocks-subdued-after-glum-novo-nordisk-ba/</guid><description>European stocks were muted on Wednesday following a slate of underwhelming results, including those from Bayer AG and Novo Nordisk A/S.</description></item><item><title>European Stocks Subdued After Glum Novo Nordisk, Bayer Earnings</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-06-european-stocks-subdued-after-glum-novo-nordisk-ba/</link><pubDate>Wed, 06 Aug 2025 07:17:42 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-06-european-stocks-subdued-after-glum-novo-nordisk-ba/</guid><description>European stocks were muted on Wednesday following a slate of underwhelming results, including those from Bayer AG and Novo Nordisk A/S.</description></item><item><title>Denmark’s Economy Runs on Novo. Will the Drugmaker’s Troubles Slim It Down?</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-08-03-denmarks-economy-runs-on-novo-will-the-drugmakers-/</link><pubDate>Sun, 03 Aug 2025 07:00:26 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-08-03-denmarks-economy-runs-on-novo-will-the-drugmakers-/</guid><description>Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of its homegrown hero, Novo Nordisk A/S. Thanks to the pharmaceutical giant’s astronomical</description></item><item><title>Denmark’s Economy Runs on Novo. Will the Drugmaker’s Troubles Slim It Down?</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-03-denmarks-economy-runs-on-novo-will-the-drugmakers-/</link><pubDate>Sun, 03 Aug 2025 07:00:26 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-03-denmarks-economy-runs-on-novo-will-the-drugmakers-/</guid><description>Denmark’s status as one of the few countries in Europe with an expanding economy rests in part on the success of its homegrown hero, Novo Nordisk A/S. Thanks to the pharmaceutical giant’s astronomical</description></item><item><title>Novo Nordisk Shares Post Worst Ever Week as Optimism Wanes</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-08-01-novo-nordisk-shares-post-worst-ever-week-as-optimi/</link><pubDate>Fri, 01 Aug 2025 08:24:53 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-08-01-novo-nordisk-shares-post-worst-ever-week-as-optimi/</guid><description>Just six weeks ago, things seemed to be getting better for Novo Nordisk A/S. Investors were optimistic, and the Danish drugmaker was briefly Europe’s most valuable public company again. Now, the stock</description></item><item><title>Novo Nordisk Shares Post Worst Ever Week as Optimism Wanes</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-01-novo-nordisk-shares-post-worst-ever-week-as-optimi/</link><pubDate>Fri, 01 Aug 2025 08:24:53 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-08-01-novo-nordisk-shares-post-worst-ever-week-as-optimi/</guid><description>Just six weeks ago, things seemed to be getting better for Novo Nordisk A/S. Investors were optimistic, and the Danish drugmaker was briefly Europe’s most valuable public company again. Now, the stock</description></item><item><title>Novo Is to Lilly What LVMH Is to Hermes, Fund Manager Reckons</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</link><pubDate>Tue, 29 Jul 2025 15:09:58 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</guid><description>A widening gulf between the stock performances of Novo Nordisk A/S and its main competitor Eli Lilly &amp;amp; Co has drawn comparison with two of the world’s largest luxury-goods makers.</description></item><item><title>Novo Is to Lilly What LVMH Is to Hermes, Fund Manager Reckons</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</link><pubDate>Tue, 29 Jul 2025 15:09:58 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</guid><description>A widening gulf between the stock performances of Novo Nordisk A/S and its main competitor Eli Lilly &amp;amp; Co has drawn comparison with two of the world’s largest luxury-goods makers.</description></item><item><title>Novo Picks Insider as CEO After Selloff From Wegovy Slump</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-novo-picks-insider-as-ceo-after-selloff-from-wegov/</link><pubDate>Tue, 29 Jul 2025 11:11:25 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-novo-picks-insider-as-ceo-after-selloff-from-wegov/</guid><description>Novo Nordisk A/S named its head of international operations as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped $93 billion off its market value.</description></item><item><title>Novo Picks Insider as CEO After Selloff From Wegovy Slump</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-novo-picks-insider-as-ceo-after-selloff-from-wegov/</link><pubDate>Tue, 29 Jul 2025 11:11:25 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-novo-picks-insider-as-ceo-after-selloff-from-wegov/</guid><description>Novo Nordisk A/S named its head of international operations as chief executive officer after slumping weight-loss drug sales led to a profit warning that wiped $93 billion off its market value.</description></item></channel></rss>